Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

At Johns Hopkins, we are leaders in pelvic health care, pioneering treatment for women year after year. Our board-certified pelvic health specialists are involved in research and clinical trials for ...

Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted ... Scientists Develop ...

The most frequent manifestation is a lichenoid reaction characterized by oral lichen planus–like lesions. The lesions may be reticular, atrophic, erosive, or plaquelike and usually abut the ...